The tumor suppressor protein p53 functions as a checkpoint during the G1 phase of the cell cycle in response to DNA damage. Mutations in the p53 gene lead to increased genomic instability and tumorigenesis. The E2F-1 transcription factor, a partner of the retinoblastoma susceptibility gene product RB, functions as a positive regulator for entry into the S phase. The study explores the interaction between p53 and E2F-1 in the cell cycle. A human E2F-1 expression plasmid was introduced into a murine cell line with a temperature-sensitive p53 allele, which produces wild-type p53 at 32°C and mutant p53 at 37.5°C. Coexpression of wild-type p53 and E2F-1 resulted in rapid cell death through apoptosis. The p53 protein can act as a transcription factor, regulating some genes positively by interacting with specific DNA elements or negatively regulating others without those elements. p53 levels increase in response to DNA damage, leading to cell cycle arrest or apoptosis. p53 may act as a checkpoint to allow DNA repair or commit cells to apoptosis. Other factors can also signal p53 to mediate apoptosis. The adenovirus E1A oncogene can initiate cell death through apoptosis, which is accompanied by increased p53 levels. The E1A oncogene encodes a protein that binds to RB, releasing active E2F transcription factors. E2F can activate genes involved in DNA replication and S phase. However, E1A also increases p53 levels, leading to a conflict between growth-promoting signals from E2F and p53-mediated cell cycle arrest. Coexpression of E2F-1 and p53 leads to apoptosis. The study shows that E2F-1 can overcome p53-mediated growth arrest and lead to cell death through apoptosis. The results indicate that p53 and E2F-1 interact in a pathway that mediates apoptosis. The findings suggest that the p53 and RB pathways communicate in checkpoint control of the cell cycle. The molecular mechanisms of this communication remain to be elucidated. The study also highlights the role of E2F-1 in overcoming p53-mediated growth arrest and the potential for conflicting signals to result in apoptosis. The results have implications for understanding the regulation of cell cycle and apoptosis by tumor suppressor genes.The tumor suppressor protein p53 functions as a checkpoint during the G1 phase of the cell cycle in response to DNA damage. Mutations in the p53 gene lead to increased genomic instability and tumorigenesis. The E2F-1 transcription factor, a partner of the retinoblastoma susceptibility gene product RB, functions as a positive regulator for entry into the S phase. The study explores the interaction between p53 and E2F-1 in the cell cycle. A human E2F-1 expression plasmid was introduced into a murine cell line with a temperature-sensitive p53 allele, which produces wild-type p53 at 32°C and mutant p53 at 37.5°C. Coexpression of wild-type p53 and E2F-1 resulted in rapid cell death through apoptosis. The p53 protein can act as a transcription factor, regulating some genes positively by interacting with specific DNA elements or negatively regulating others without those elements. p53 levels increase in response to DNA damage, leading to cell cycle arrest or apoptosis. p53 may act as a checkpoint to allow DNA repair or commit cells to apoptosis. Other factors can also signal p53 to mediate apoptosis. The adenovirus E1A oncogene can initiate cell death through apoptosis, which is accompanied by increased p53 levels. The E1A oncogene encodes a protein that binds to RB, releasing active E2F transcription factors. E2F can activate genes involved in DNA replication and S phase. However, E1A also increases p53 levels, leading to a conflict between growth-promoting signals from E2F and p53-mediated cell cycle arrest. Coexpression of E2F-1 and p53 leads to apoptosis. The study shows that E2F-1 can overcome p53-mediated growth arrest and lead to cell death through apoptosis. The results indicate that p53 and E2F-1 interact in a pathway that mediates apoptosis. The findings suggest that the p53 and RB pathways communicate in checkpoint control of the cell cycle. The molecular mechanisms of this communication remain to be elucidated. The study also highlights the role of E2F-1 in overcoming p53-mediated growth arrest and the potential for conflicting signals to result in apoptosis. The results have implications for understanding the regulation of cell cycle and apoptosis by tumor suppressor genes.